27 related articles for article (PubMed ID: 10321115)
1. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
2. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Basu D; Siegel BA; McDonald DJ; Nussenbaum B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
[TBL] [Abstract][Full Text] [Related]
3. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
4. [Positron emission tomography of the skeletal system using 18FNa: frequency, distribution and appearance of skeletal metastases].
Schirrmeister H; Guhlmann CA; Elsner K; Nüssle K; Träger H; Kotzerke J; Reske SN
Rontgenpraxis; 1999; 52(1):19-25. PubMed ID: 10321115
[No Abstract] [Full Text] [Related]
5. Bone imaging in metastatic breast cancer.
Hamaoka T; Madewell JE; Podoloff DA; Hortobagyi GN; Ueno NT
J Clin Oncol; 2004 Jul; 22(14):2942-53. PubMed ID: 15254062
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone.
Ghanem N; Uhl M; Brink I; Schäfer O; Kelly T; Moser E; Langer M
Eur J Radiol; 2005 Jul; 55(1):41-55. PubMed ID: 15950100
[TBL] [Abstract][Full Text] [Related]
7. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
Horger M; Bares R
Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
[TBL] [Abstract][Full Text] [Related]
8. The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response.
Erasmus JJ; Munden RF
Semin Radiat Oncol; 2007 Jan; 17(1):29-37. PubMed ID: 17185195
[TBL] [Abstract][Full Text] [Related]
9. Developments in instrumentation for emission computed tomography.
Daube-Witherspoon ME; Zubal IG; Karp JS
Semin Nucl Med; 2003 Jan; 33(1):28-41. PubMed ID: 12605355
[TBL] [Abstract][Full Text] [Related]
10. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities.
Even-Sapir E
J Nucl Med; 2005 Aug; 46(8):1356-67. PubMed ID: 16085595
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
